References
- TosMEpidemiology and natural history of secretory otitisAm J Otol1984564594626542752
- BurrowsHLBlackwoodRACookeJMCookeJMHarrisonRVPassamaniPPOtitis Media Guideline TeamUniversity of Michigan Health System: Otitis Media Guideline2013
- LoosBGBernsteinJMDryjaDMMurphyTFDickinsonDPDetermination of the epidemiology and transmission of non-typable Haemophilus influenza in children with otitis media by comparison of total genomic DNA restriction fingerprintsInfect Immun1989579275127572788138
- RosenfeldRMSchwartzSRPynnonenMAClinical practice guideline: tympanostomy tubes in childrenOtolaryngol Head Neck Surg2013149Suppl 1S1S3523818543
- GluthMBMcDonaldDRWeaverALBauchCDBeattyCWOrvidasLJManagement of eustachian tube dysfunction with nasal steroid spray: a prospective, randomized, placebo-controlled trialArch Otolaryngol Head Neck Surg2011137544945521576556
- American Academy of Family PhysiciansAmerican Academy of Otolaryngology-Head and Neck SurgeryAmerican Academy of Pediatrics Subcommittee on Otitis Media with EffusionOtitis media with effusionPediatrics200411351412142915121966
- BrookIGoberAEIn vitro bacterial interference in the nasopharynx of otitis media-prone and non-otitis media-prone childrenArch Otolaryngol Head Neck Surg20001261011101310922236
- BernsteinJMFadenHFDryjaDMWactawski-WendeJMicro-ecology of the nasopharyngeal bacterial flora in otitis-prone and non-otitis-prone childrenActa Otolaryngol199311388928442428
- TanoKOlofssonCGrahn-HakanssonEHolmSEIn vitro inhibition of S pneumoniae, non-typable H. influenzae and M. catarrhalis by alpha-hemolytic streptococci from healthy childrenInt J Pediatr Otorhinolaryngol199947495610206394
- RoosKHakanssonEGHolmSEffect of re-colonization with “interfering” alpha streptococci on recurrences of acute and secretory otitis media in children: randomized placebo controlled trialBMJ200132221021211159619
- SkovbjergSRoosKHolmSESpray bacteriotherapy decreases middle ear fluid in children with secretory otitis mediaArch Dis Child2009942929818713796
- WescombePAHaleJDHengNCTaggJRDeveloping oral probiotics from Streptococcus salivariusFuture Microbiol20127121355137123231486
- TaggJRPrevention of streptococcal pharyngitis by anti-Streptococcus pyogenes bacteriocin-like inhibitory substances (BLIS) produced by Streptococcus salivariusIndian J Med2004119Suppl1316
- HyinkOWescombePAUptonMRaglandNBurtonJPTaggJRSalivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12Appl Environ Microbiol20077341107111317194838
- SharmaSVermaKKSkin and soft tissue infectionIndian J Pediatr200168Suppl 3S46S5011980459
- WescombePABurtonJPCadieuxPAMegaplasmids encode differing combinations of lantibiotics in Streptococcus salivariusAntonie Van Leeuwenhoek200690326928016871420
- van ZonAvan der HeijdenGJvan DongenTMBurtonMJSchilderAGAntibiotics for otitis media with effusion in childrenCochrane Database Syst Rev20129CD00916322972136
- PowerDABurtonJPChilcottCNDawesPJTaggJRPreliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12Eur J Clin Microbiol Infect Dis200827121261126318560907
- HorzHPMeineltAHoubenBConradsGDistribution and persistence of probiotic Streptococcus salivarius K12 in the human oral cavity as determined by real-time quantitative polymerase chain reactionOral Microbiol Immunol200722212613017311636
- BurtonJPWescombePAMooreCJChilcottCNTaggJRSafety assessment of the oral cavity probiotic Streptococcus salivarius K12Appl Environ Microbiol20067243050305316598017
- BurtonJPCowleySSimonRRMcKinneyJWescombePATaggJREvaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a randomized, placebo-controlled, double-blind studyFood Chem Toxicol20114992356236421722694
- Di PierroFAdamiTRapacioliGGiardiniNStreitbergerCClinical evaluation of the oral probiotic Streptococcus salivarius K12 in the prevention of recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes in adultsExpert Opin Biol Ther201313333934323286823
- Di PierroFDonatoGFomiaFPreliminary pediatric clinical evaluation of the oral probiotic Streptococcus salivarius K12 in preventing recurrent pharyngitis and/or tonsillitis caused by Streptococcus pyogenes and recurrent acute otitis mediaInt J Gen Med2012599199723233809
- Di PierroFColomboMZanvitARissoPRottoliASUse of Streptococcus salivarius K12 in the prevention of streptococcal and viral pharyngotonsillitis in childrenDrug Healthc Patient Saf20146152024600248
- NorthernJLDownsMPHearing in Children3rd edPhiladelphia, PAWilliams and Wilkins1984
- FriedmanMTanyeriHLa RosaMClinical predictors of obstructive sleep apneaLaryngoscope19991091901190710591345
- MatarGMSidaniNFayadMHadiUTwo-step PCR-based assay for identification of bacterial etiology of otitis media with effusion in infected Lebanese childrenJ Clin Microbiol199836118511889574673
- SchousboeLPOvesenTEckhardtLRasmussenLMPedersenCBHow does endotoxin trigger inflammation in otitis media with effusion?Laryngoscope2001111229730011210878
- IshijimaSAHayamaKBurtonJPEffect of Streptococcus salivarius K12 on the in vitro growth of Candida albicans and its protective effect in an oral candidiasis modelAppl Environ Microbiol20127872190219922267663